¼¼°èÀÇ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå : ¼ºÀå, Àü¸Á, °æÀï ºÐ¼®(2025-2033³â)
Single-use Centrifuge System Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
»óǰÄÚµå : 1675062
¸®¼­Ä¡»ç : Acute Market Reports
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 172 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,333,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,500 £Ü 9,148,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 9,000 £Ü 12,667,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀåÀº »ý¸í°øÇÐ ¹× Á¦¾à ¾÷°è¿¡¼­ ÇÑ ¹ø »ç¿ëÇÏ¸é Æó±âµÇµµ·Ï ¼³°èµÈ ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ¿¡ ÃÊÁ¡À» ¸ÂÃá ºÎ¹®À» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀϹÝÀûÀ¸·Î ÀÏȸ¿ë ·ÎÅÍ ¾î¼Àºí¸®¿Í ¿ë±â·Î ±¸¼ºµÇ¸ç ¿ø½É·ÂÀ¸·Î ¾×ü »ùÇÿ¡¼­ ÀÔÀÚ¿Í ¼¼Æ÷¸¦ ºÐ¸®ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¹é½Å, ´ÜŬ·ÐÇ×ü ¹× ±âŸ »ý¹°ÇÐÀû Á¦Á¦ÀÇ Á¦Á¶¿Í °°Àº ³ôÀº ¹«±Õ¼ºÀÌ ¿ä±¸µÇ¸ç ±³Â÷ ¿À¿°À» ÇÇÇÒ ¼ö ¾ø´Â ¿ëµµ¿¡¼­´Â ÀÏȸ¿ë À¯ÇüÀÎ °ÍÀÌ Æ¯È÷ À¯¸®ÇÕ´Ï´Ù. ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀåÀº ¹ÙÀÌ¿À ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í »ý¸í°úÇÐ »ê¾÷¿¡¼­ À¯¿¬ÇÏ°í ¿À¿°µÇÁö ¾ÊÀº Á¦Á¶ °øÁ¤¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. CAGRÀº 5.6%·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, ÀÌ ½ÃÀåÀº ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÐ¾ß¿¡¼­ÀÇ Çõ½Å°ú Áö¼Ó°¡´É¼ºÀ̶ó´Â Æø³ÐÀº µ¿Çâ¿¡ ÀûÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ±â¼úÀ» äÅÃÇϸé û¼Ò ¿ä±¸ »çÇ×°ú °¡µ¿ ÁßÁö ½Ã°£À» ÁÙÀÏ ¼ö ÀÖÀ¸¹Ç·Î ¾÷¹« È¿À²ÀÌ Çâ»óµÇ°í ±³Â÷ ¿À¿° À§ÇèÀÌ ÁÙ¾î µì´Ï´Ù.

ÃËÁø¿äÀÎ: ¹ÙÀÌ¿ÀÀǾàǰ ¼ö¿ä Áõ°¡

¹é½Å, ´ÜŬ·Ð Ç×ü, ¼¼Æ÷ Ä¡·á µî ¹ÙÀÌ¿À ÀǾàǰ¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡°¡ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°ÀÇ °³¹ß°ú Á¦Á¶¿¡´Â ¿À¿°À» ¹æÁöÇϰí Á¦Ç°ÀÇ ¹«°á¼ºÀ» º¸ÀåÇϱâ À§ÇØ °í±Þ ¹«±Õ »óŰ¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛÀº ¹èÄ¡ »çÀÌÀÇ 2Â÷ ¿À¿° À§ÇèÀ» ¾ø¾Ö°í Àç»ç¿ë ½Ã½ºÅÛÀÇ ¼¼Ã´ ¹× ¸ê±Õ°ú °ü·ÃµÈ ´Ù¿îŸÀÓÀ» Å©°Ô ÁÙÀÔ´Ï´Ù. ÀÌ´Â ¾ÈÀü°ú È¿´ÉÀÌ °¡Àå Áß¿ä½ÃµÇ´Â ±ÔÁ¦ ȯ°æ¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀº ¹é½Å »ý»ê ´É·ÂÀÇ ½Å¼ÓÇÑ È®ÀåÀÇ Çʿ伺À» º¸¿©ÁÖ¾úÀ¸¸ç, ÀÏȸ¿ë ±â¼úÀº ¼¼°è ¼ö¿ä¸¦ ½Å¼ÓÇÏ°Ô ÃæÁ·½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çß½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ ½ÃÀåÀÌ »õ·Î¿î »ý¹°ÇÐÀû Ä¡·á¿Í °³ÀÎÈ­µÈ ÀÇ·á Á¢±Ù ¹æ½ÄÀ¸·Î °è¼Ó È®´ëµÇ°í ÀÖ´Â µ¿¾È, ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í Á¦Ç° °³¹ß »çÀÌŬÀÇ °¡¼ÓÈ­¿Í À¯¿¬ÇÑ Á¦Á¶ ¼³Á¤ÀÌ Áö¿øµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±âȸ: ÀÏȸ¿ë ±â¼úÀÇ Áøº¸

ÀÏȸ¿ë ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸´Â ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½ÃÀå¿¡ Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ È¿À²¼º, È®À强 ¹× ȯ°æ Áö¼Ó°¡´É¼ºÀ» Çâ»ó½ÃŰ´Â ±â¼ú Çõ½ÅÀº ÇöÀçÀÇ ÇѰ踦 ´Ù·ç°í ±× ¿ëµµ¸¦ È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÀÏȸ¿ë ±¸¼º ¿ä¼ÒÀÇ »ýºÐÇØ¼º Àç·á ¹× ÀçȰ¿ë ÇÁ·Î¼¼½º¸¦ °³¹ßÇϸé ÀÏȸ¿ë ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ´ë¿ë·®È­¿Í º¸´Ù Á¤¹ÐÇÑ ºÐ¸®¿¡ ´ëÀÀÇÏ´Â ¼³°èÀÇ °³¼±À¸·Î ÀÏȸ¿ë ¿ø½É±â¸¦ º¸´Ù Æø³ÐÀº ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ÀÛ¾÷¿¡ ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾î »ý¹°Á¦Á¦ÀÇ ´ë±Ô¸ð »ý»ê Áõ°¡ Ãß¼¼¸¦ ĸóÇÒ ¼ö ÀÖ½À´Ï´Ù.

¾ïÁ¦¿äÀÎ: ³ôÀº ºñ¿ë°ú ȯ°æ¿¡ ´ëÇÑ ¿ì·Á

ÀÌÁ¡¿¡µµ ºÒ±¸Çϰí, ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀº Å« Á¦¾àÀ̵˴ϴÙ. »õ·Î¿î ¹èÄ¡ ÇÁ·Î¼¼½º¸¶´Ù ¸Å¹ø ÀÏȸ¿ë ±¸¼º ¿ä¼ÒÀÇ »õ·Î¿î ¼¼Æ®°¡ ÇÊ¿äÇϹǷΠ±âÁ¸ Àç»ç¿ë °¡´ÉÇÑ ½Ã½ºÅÛÀÇ ÀÏȸ¼º ÅõÀÚ ¹× ¹Ýº¹ »ç¿ë¿¡ ºñÇØ °æÁ¦Àû ºÎ´ãÀÌ Ä¿Áú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á Æó±â¹°À» ÀÏÀ¸Å°´Â ÀÏȸ¿ë Á¦Ç° Æó±â¿¡ ´ëÇÑ È¯°æ ¿ì·Áµµ ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀÎÀº ¼Ò±Ô¸ð Á¦Á¶¾÷ü³ª Æó±â¹° ó¸® ±ÔÁ¦°¡ ¾ö°ÝÇÑ Áö¿ªÀÇ Á¦Á¶¾÷ü°¡ ÀÏȸ¿ë ±â¼úÀÇ Ã¤¿ëÀ» ¸Á¼³ÀÌ°í ½ÃÀå ÀüüÀÇ È®´ë¿¡ ¿µÇâÀ» ¹ÌÄ¥ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

°úÁ¦: Æó±â¹° °ü¸® ¹× Áö¼Ó°¡´É¼º ¹®Á¦

ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀåÀÌ Á÷¸éÇÑ ÁÖ¿ä °úÁ¦´Â ÀÏȸ¿ë ºÎǰ¿¡¼­ ¹ß»ýÇÏ´Â Æó±â¹° °ü¸® ¹× Áö¼Ó°¡´É¼º ¹®Á¦¿¡ ´ëÇÑ ´ëÀÀÀÔ´Ï´Ù. ÀÏȸ¿ë ½Ã½ºÅÛÀÇ µµÀÔÀÌ ÁøÇàµÊ¿¡ µû¶ó ÇÃ¶ó½ºÆ½À̳ª »ýºÐÇØ¼ºÀÌ ¾ø´Â Æó±â¹°ÀÇ ¾çµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̴ ȯ°æ ½ÇÀû¸¦ ÁÙÀÌ´Â µ¥ Á¡Á¡ ´õ ÁßÁ¡À» µÎ°í ÀÖ´Â ¾÷°èÀÇ ½É°¢ÇÑ ¿ì·ÁÀÔ´Ï´Ù. »ç¿ëµÈ ºÎǰÀ» ÀçȰ¿ëÇÏ´Â ¹æ¹ýÀ» ã°Å³ª º¸´Ù Áö¼Ó °¡´ÉÇÑ ÀÏȸ¿ë ½Ã½ºÅÛ¿ë ¼ÒÀ縦 °³¹ßÇÏ´Â °ÍÀº ½ÃÀåÀÇ ¼ºÀå°ú ¼ö¿ëÀ» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¿¡´Â Çõ½ÅÀûÀÎ Á¢±Ù ¹æ½Ä°ú ¾÷°è Àü¹ÝÀÇ Çù·ÂÀ» ÅëÇØ ¾÷¹« È¿À²¼º°ú ȯ°æ¿¡ ´ëÇÑ Ã¥ÀÓÀ» ¾ç¸³½ÃŰ´Â ¼Ö·ç¼ÇÀ» °³¹ßÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù.

À¯Çüº° ½ÃÀå ±¸ºÐ

ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå¿¡¼­´Â Ź»óÇü ¿ø½ÉºÐ¸®±â¿Í ¿¬¼Ó È帧Çü ¿ø½ÉºÐ¸®±â°¡ À¯Çüº°·Î ¼¼ºÐÈ­µË´Ï´Ù. Ź»óÇü ¿ø½ÉºÐ¸®±â´Â ¿¬±¸°³¹ß, ƯÈ÷ Á¦¾à ¹× »ý¸í°øÇÐ ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ÇöÀç °¡Àå ³ôÀº ÆÇ¸Å¸¦ ÀÚ¶ûÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÀåÄ¡´Â ¼ÒÇü Å©±â, »ç¿ë ÆíÀǼº ¹× À¯¿¬¼ºÀ» Áö¿øÇÏ¸ç ¼Ò±Ô¸ð ½ÇÇè ¹× »ý»ê °øÁ¤¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ÇÑÆí, CAGRÀÌ °¡Àå ³ôÀº °ÍÀ¸·Î ¿¹»óµÇ´Â °ÍÀº ¿¬¼Ó À¯µ¿ ¿ø½ÉºÐ¸®±â ºÐ¾ßÀÔ´Ï´Ù. ÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀº È¿À²°ú 󸮷®ÀÌ Áß¿äÇÑ ¹ÙÀÌ¿À Á¦Á¶ ȯ°æ¿¡¼­ ¿¬¼Ó ó¸®ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ¿¬¼Ó È帧 ¿ø½ÉºÐ¸®±â´Â ´ë·®ÀÇ »ý¹°ÇÐÀû Àç·áÀÇ Ã³¸®¸¦ °¡´ÉÇÏ°Ô Çϸç, ƯÈ÷ ¹é½Å ¹× ´ÜŬ·ÐÇ×üÀÇ Á¦Á¶¿Í °°Àº »ó¾÷È­¸¦ À§ÇÑ »ý»êÀÇ ½ºÄÉÀÏ ¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù.

¿ëµµº° ½ÃÀå ±¸ºÐ

ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀåÀº ¿ëµµº°·Î ¹é½Å Á¦Á¶, Ç÷¾× ó¸®, ¼¼Æ÷ äÃë/Á¤Á¦ µîÀ¸·Î ±¸ºÐµË´Ï´Ù. ¹é½Å Á¦Á¶ ºÐ¾ß´Â ¹é½Å Á¦Á¶ ¹× Á¤Á¦¿¡¼­ ¿ø½ÉºÐ¸®ÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ¹Ý¿µÇÏ¿© °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÕ´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ÀÌÁ¡Àº ƯÈ÷ COVID-19 ÆÒµ¥¹Í ´ëÀÀ¿¡ ÀÇÇØ °­Á¶µÈ ¹é½Å ¿¬±¸ ¹× »ý»ê ¼¼°è Áõ°¡¿¡ ÀÇÇØ °­È­µÇ¾ú½À´Ï´Ù. ÇÑÆí, CAGRÀÌ °¡Àå ³ôÀº °ÍÀ¸·Î ¿¹»óµÇ´Â °ÍÀº ¼¼Æ÷ äÃë/Á¤Á¦ ºÐ¾ßÀÔ´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷ÀÌ Áٱ⼼Æ÷ ¹× Àç»ýÀǷḦ Æ÷ÇÔÇÑ ¼¼Æ÷±â¹ÝÀÇ Ä¡·á¹ý¿¡ ´ëÇÑ ÅõÀÚ¸¦ °è¼ÓÇÏ´Â °¡¿îµ¥, ¼¼Æ÷ ¹è¾çÀÇ Ã¤Ãë¿Í Åõ¸íÈ­¸¦ À§ÇÑ È¿°úÀûÀÌ°í ¹«±ÕÀÇ ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ³ôÀº ¼öÀ²°ú ¼øµµ¸¦ È®º¸Çϸ鼭 »ì¾ÆÀÖ´Â ¼¼Æ÷ÀÇ ¼¶¼¼ÇÑ ¼ºÁú¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛÀÇ Çʿ伺À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Áö¸®Àû ºÎ¹®

ºÏ¹Ì´Â °ßÁ¶ÇÑ Á¦¾à ¹× »ý¸í°øÇÐ ºÎ¹®, ¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸¿¡ ´ëÇÑ ¸¹Àº ÅõÀÚ, ³ôÀº ¼öÁØÀÇ °øÁ¤ Á¦¾î ¹× ¿À¿° ¹æÁö¸¦ ¿ä±¸ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ºÏ¹ÌÀÇ ¸®´õ½ÊÀº ÁÖ¿ä ¹ÙÀÌ¿À ÀǾàǰ ±â¾÷ÀÇ Á¸Àç¿Í °í±Þ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿¡ ÀÇÇØ ´õ¿í Áö¿øµË´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñÀÇ ±Þ¼ÓÇÑ ¼ºÀå, »ý¸í°øÇÐ ÅõÀÚ Áõ°¡, Áß±¹ ¹× Àεµ µî ±¹°¡¿¡¼­ ¹ÙÀÌ¿ÀÀǾàǰÀÇ ÇöÁö »ý»êÀ» Áö¿øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀ¸·Î 2025³âºÎÅÍ 2033³â±îÁö °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ÀǾàǰ Á¦Á¶ ´É·Â°ú ÀÎÇÁ¶óÀÇ È®´ë´Â ¼öÃâ ½ÃÀå¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ÇÔ²² ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ µîÀÇ Ã·´Ü ±â¼úÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

°æÀï µ¿Çâ°ú ÁÖ¿ä Àü·«

°æÀï ±¸µµ¿¡¼­´Â Beckman Coulter, Inc.(a Danaher Corporation company), Sartorius AG, Becton, Dickinson and Company, Merck KGaA, Thermo Fisher Scientific, Inc., Alfa Laval, Pneumatic Scale Angelus, GEA Group Aktiengesellschaft µîÀÇ ÁÖ¿ä ±â¾÷ÀÌ ½ÃÀå¿¡ ±â¿©ÇÕ´Ï´Ù. 2024³â ÀÌ ±â¾÷µéÀº ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶ÀÇ ¾ö°ÝÇÑ ¿ä±¸»çÇ×À» ÃæÁ·Çϵµ·Ï Á¶Á¤µÈ Çõ½ÅÀ» ÅëÇØ Á¦Ç° Æ÷Æ®Æú¸®¿À È®´ë¿¡ ÁÖ·ÂÇß½À´Ï´Ù. Àü·«Àû Á¦ÈÞ¿Í Àμöµµ Ȱ¹ßÇÏ°í ±â¼ú·Â °­È­¿Í Áö¸®Àû Á¸Àç È®´ë¸¦ ¸ñÀûÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Beckman Coulter´Â Danaher¿ÍÀÇ Á¦ÈÞ¸¦ Ȱ¿ëÇÏ¿© ¿¬±¸°³¹ß ´É·ÂÀ» °­È­Çϰí, º¸´Ù ´Ù¿ëµµ·Î È¿À²ÀûÀÎ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½Ã½ºÅÛÀ» µµÀÔÇß½À´Ï´Ù. Sartorius AG¿Í Merck KGaA´Â ÀÏȸ¿ë ½Ã½ºÅÛÀÇ ¼º´É°ú ¸ð´ÏÅ͸µÀ» ÃÖÀûÈ­Çϱâ À§ÇØ ¼¾¼­¿Í ÀÚµ¿È­ ±â´ÉÀÇ ÅëÇÕ¿¡ ÃÊÁ¡À» ¸ÂÃß°í ¾÷°èÀÇ ½º¸¶Æ® ¹ÙÀÌ¿À Á¦Á¶ ȯ°æÀ¸·ÎÀÇ ÀüȯÀ» µ½½À´Ï´Ù. 2025³âºÎÅÍ 2033³â±îÁö, ÀÌµé ±â¾÷Àº ÀÏȸ¿ë Á¦Ç°°ú °ü·ÃµÈ ȯ°æ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ Ä£È¯°æ ÀÏȸ¿ë ±¸¼º ¿ä¼Ò °³¹ß ¹× ÀçȰ¿ë ±â¼ú °­È­ µî Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ ³ë·Â¿¡ ÁÖ·ÂÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ½ÃÀåÀÌ ½ÅÈï Áö¿ªÀ¸·Î È®´ëµÊ¿¡ µû¶ó °æÀï ¿ìÀ§¸¦ À¯ÁöÇÏ°í ¼¼°è ½ÃÀåÀ¸·ÎÀÇ Ä§Åõ¸¦ ÃËÁøÇϱâ À§Çؼ­´Â ÇöÁö ±ÔÁ¦ ¹× ¿î¿µ ¿ä±¸ »çÇ׿¡ ¸Â°Ô Á¦Ç°À» ¸ÂÃãÈ­ÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå : °æÀï ºÐ¼®

Á¦4Àå ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå : ¸ÅÅ©·Î ºÐ¼®°ú ½ÃÀå ¿ªÇÐ

Á¦5Àå ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå : À¯Çüº°(2023-2033³â)

Á¦6Àå ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°(2023-2033³â)

Á¦7Àå ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2023-2033³â)

Á¦8Àå ºÏ¹ÌÀÇ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå(2023-2033³â)

Á¦9Àå ¿µ±¹ ¹× EUÀÇ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå(2023-2033³â)

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå(2023-2033³â)

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå(2023-2033³â)

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÏȸ¿ë ¿ø½ÉºÐ¸®±â ½Ã½ºÅÛ ½ÃÀå(2023-2033³â)

Á¦13Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The single-use centrifuge system market refers to the segment of the biotechnology and pharmaceutical industries focused on centrifuge systems designed to be used once and then discarded. These systems typically consist of disposable rotor assemblies and containers that are used to separate particles or cells in liquid samples through centrifugal force. The single-use nature of these systems is particularly advantageous in applications requiring high standards of sterility, such as in the production of vaccines, monoclonal antibodies, and other biologics, where cross-contamination must be avoided. The single-use centrifuge system market is experiencing growth driven by the increasing demand for biopharmaceuticals and the rising need for flexible, contamination-free manufacturing processes in the life sciences industry. With a projected compound annual growth rate (CAGR) of 5.6%, this market is adapting to the broader trends of innovation and sustainability within the pharmaceutical and biotechnological sectors. The adoption of single-use technologies helps in reducing cleaning requirements and downtime, thus enhancing operational efficiencies and reducing the risk of cross-contamination.

Driver: Growing Demand for Biopharmaceuticals

The surging global demand for biopharmaceuticals, including vaccines, monoclonal antibodies, and cell therapies, significantly drives the single-use centrifuge system market. The development and manufacturing of these products require highly sterile conditions to prevent contamination and ensure product integrity. Single-use centrifuge systems eliminate the risk of cross-contamination between batches and significantly reduce the downtime associated with cleaning and sterilization in multi-use systems. This is particularly crucial in a regulatory environment where safety and efficacy are paramount. The COVID-19 pandemic exemplified the need for rapid scaling of vaccine production capabilities, where single-use technologies played a critical role in meeting global demand swiftly. As the biopharmaceutical market continues to expand with new biological treatments and personalized medicine approaches, the reliance on single-use centrifuge systems is expected to increase, supporting faster product development cycles and flexible manufacturing setups.

Opportunity: Advances in Single-Use Technologies

Technological advancements in single-use systems present significant opportunities for the single-use centrifuge market. Innovations that enhance the efficiency, scalability, and environmental sustainability of these systems can address some of the current limitations and broaden their applications. For instance, developments in biodegradable materials and recycling processes for single-use components can help mitigate the environmental impact associated with disposables. Additionally, improvements in design to accommodate larger volumes or more precise separations can make single-use centrifuges viable for a wider range of bioprocessing tasks, tapping into the growing trend of large-scale biologics production.

Restraint: High Cost and Environmental Concerns

Despite their advantages, the high costs associated with single-use centrifuge systems pose a significant restraint. Each new batch process requires a new set of disposable components, which can be financially burdensome compared to the one-time investment and repeated use of traditional, reusable systems. Furthermore, environmental concerns over the disposal of single-use products, which contribute to medical waste, also restrain market growth. These factors can deter smaller manufacturers or those in regions with strict waste disposal regulations from adopting single-use technologies, affecting the overall expansion of the market.

Challenge: Waste Management and Sustainability Issues

A major challenge facing the single-use centrifuge system market is managing the waste generated by disposable components and addressing sustainability issues. As the adoption of single-use systems grows, so does the volume of plastic and non-biodegradable waste. This is a significant concern in an industry increasingly focused on reducing its environmental footprint. Finding ways to recycle used components or developing more sustainable materials for single-use systems are crucial for maintaining market growth and acceptance. These challenges require innovative approaches and collaboration across the industry to develop solutions that balance operational efficiency with environmental responsibility.

Market Segmentation by Type

In the single-use centrifuge system market, segmentation by type includes Benchtop Centrifuge and Continuous Flow Centrifuge. The Benchtop Centrifuge segment currently holds the highest revenue due to its widespread use in laboratory settings for research and development, particularly in the pharmaceutical and biotechnological sectors. These units are favored for their compact size, ease of use, and flexibility, making them ideal for small-scale experiments and production processes. On the other hand, the Continuous Flow Centrifuge segment is expected to register the highest CAGR. This growth is driven by the increasing adoption of continuous processing in biomanufacturing environments where efficiency and throughput are critical. Continuous flow centrifuges allow for the processing of large volumes of biological materials, which is essential in the scale-up of production for commercialization, especially in vaccine and monoclonal antibody manufacturing.

Market Segmentation by Application

Regarding applications, the single-use centrifuge system market is segmented into Vaccine Manufacturing, Blood Processing, Cell Harvest/Clarification, and Others. The Vaccine Manufacturing segment generates the highest revenue, reflecting the crucial role of centrifugation in the production and purification of vaccines. This segment's dominance is bolstered by the global increase in vaccine research and production, particularly highlighted by the COVID-19 pandemic response. Meanwhile, the Cell Harvest/Clarification segment is anticipated to experience the highest CAGR. As biopharmaceutical companies continue to invest in cell-based therapies, including stem cell and regenerative medicine, the demand for effective and sterile methods to harvest and clarify cell cultures is growing. This trend is propelling the need for innovative single-use centrifuge systems that can accommodate the delicate nature of living cells while ensuring high yields and purity.

Geographic Segment

The single-use centrifuge system market showcases diverse geographic trends, with North America holding the highest revenue percentage in 2024, driven by robust pharmaceutical and biotechnology sectors, substantial investments in biopharmaceutical research, and stringent regulatory standards requiring high levels of process control and contamination prevention. North America's leadership is further supported by the presence of major biopharmaceutical companies and advanced healthcare infrastructure. Asia Pacific, however, is expected to exhibit the highest CAGR from 2025 to 2033, due to rapid growth in healthcare expenditure, increasing investments in biotechnology, and government initiatives to support local production of biopharmaceuticals in countries like China and India. The expanding capabilities and infrastructure for pharmaceutical manufacturing in the region, coupled with a growing focus on export markets, are driving the adoption of advanced technologies, including single-use centrifuge systems.

Competitive Trends and Key Strategies

In the competitive landscape, major players such as Beckman Coulter, Inc. (a Danaher Corporation company), Sartorius AG, Becton, Dickinson and Company, Merck KGaA, Thermo Fisher Scientific, Inc., Alfa Laval, Pneumatic Scale Angelus, and GEA Group Aktiengesellschaft have been instrumental in shaping the market dynamics. In 2024, these companies focused on expanding their product portfolios through innovations tailored to meet the rigorous requirements of biopharmaceutical manufacturing. Strategic alliances and acquisitions were prevalent, aimed at enhancing their technological capabilities and expanding their geographical presence. Beckman Coulter, for instance, leveraged its association with Danaher to enhance its R&D capabilities, introducing more versatile and efficient single-use centrifugal systems. Sartorius AG and Merck KGaA concentrated on integrating sensors and automation features to optimize the performance and monitoring of their single-use systems, aligning with the industry's shift towards smart bio manufacturing environments. From 2025 to 2033, these companies are expected to focus on sustainability initiatives, such as developing eco-friendlier disposable components and enhancing recycling technologies to address environmental concerns associated with single-use products. Moreover, as the market expands into emerging regions, customization of products to suit local regulatory and operational requirements will be crucial for maintaining competitive advantage and facilitating global market penetration.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Single-use Centrifuge System market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Single-use Centrifuge System market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Key questions answered in this report

Table of Contents

1. Preface

2. Executive Summary

3. Single-use Centrifuge System Market: Competitive Analysis

4. Single-use Centrifuge System Market: Macro Analysis & Market Dynamics

5. Single-use Centrifuge System Market: By Type, 2023-2033, USD (Million)

6. Single-use Centrifuge System Market: By Application, 2023-2033, USD (Million)

7. Single-use Centrifuge System Market: By End-user, 2023-2033, USD (Million)

8. North America Single-use Centrifuge System Market, 2023-2033, USD (Million)

9. UK and European Union Single-use Centrifuge System Market, 2023-2033, USD (Million)

10. Asia Pacific Single-use Centrifuge System Market, 2023-2033, USD (Million)

11. Latin America Single-use Centrifuge System Market, 2023-2033, USD (Million)

12. Middle East and Africa Single-use Centrifuge System Market, 2023-2033, USD (Million)

13. Company Profile

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â